European guidelines on cardiovascular disease prevention in clinical practice: executive summary
Raffaele De Caterina, Veronica Dean, Kenneth Dickstein, Christian Funck-Brentano, Gerasimos Filippatos, Irene Hellemans, Steen Dalby Kristensen, Keith McGregor, Udo Sechtem, Sigmund Silber, Michal Tendera, Petr Widimsky, José Luis Zamorano, Enzo Bonora, Robert Fagard, Simona Giampaoli, Jan Hakansson, Sverre Erik Kjeldsen, Mogens Lytken Larsen, Giuseppe Mancia, Athanasios J Manolis, Kristina Orth-Gomer, Terje Pedersen, Lars Ryden
2007-01-01
Abstract:The rationale for an active approach to the prevention of atherosclerotic cardiovascular disease (CVD) is based on five key points:By the early 1990s there was a plethora of similar yet confusingly different national and international guidelines for the prevention of CVD. In order to try to define the areas of agreement, the ESC, the European Atherosclerosis Society and the European Society of Hypertension agreed to collaborate, resulting in a set of recommendations for the prevention of coronary heart disease (CHD) that was published in 1994. 1 These guidelines were revised in 1998 and 2003 by the second and third Joint Task Forces. 2, 3 A strength of the guidelines is that, from the outset, it was stressed that CVD is usually the product of multiple interacting risk factors. This resulted in the production of risk charts that attempt to simplify the estimation of total CVD risk, and a realization that risk management requires attention to all modifiable risk factors. It was appreciated that the original partners needed assistance from other bodies and experts, in particular in the fields of behavioural medicine and diabetes. In addition, it is acknowledged that much practical preventive advice is delivered by family doctors, nurses, and through voluntary bodies such as Heart Foundations. These considerations are reflected in the expanded partnership represented in the present guidelines, and in the list of experts whose input has been sought.